Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Oral Cyclophosphamide in Advanced Sarcomas
NCT01716689Phase 2Completed
- Sponsor
- National Cancer Centre Singapore
- Start
- Jun 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in sarcoma, sponsored by National Cancer Centre Singapore. Started Jun 2012; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT01716689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716689.